Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences.

The mutagenic and carcinogenic chemical aflatoxin B1 (AFB1) reacts almost exclusively at the N(7)-position of guanine following activation to its reactive form, the 8,9-epoxide (AFB1 oxide). In general N(7)-guanine adducts yield DNA strand breaks when heated in base, a property that serves as the basis for the Maxam-Gilbert DNA sequencing reaction specific for guanine. Using DNA sequencing methods, other workers have shown that AFB1 oxide gives strand breaks at positions of guanines; however, the guanine bands varied in intensity. This phenomenon has been used to infer that AFB1 oxide prefers to react with guanines in some sequence contexts more than in others and has been referred to as "sequence specificity of binding". Herein, data on the reaction of AFB1 oxide with several synthetic DNA polymers with different sequences are presented, and (following hydrolysis) adduct levels are determined by high-pressure liquid chromatography. These results reveal that for AFB1 oxide (1) the N(7)-guanine adduct is the major adduct found in all of the DNA polymers, (2) adduct levels vary in different sequences, and, thus, sequence specificity is also observed by this more direct method, and (3) the intensity of bands in DNA sequencing gels is likely to reflect adduct levels formed at the N(7)-position of guanine. Knowing this, a reinvestigation of the reactivity of guanines in different DNA sequences using DNA sequencing methods was undertaken. The reactivities of 190 guanines were determined quantitatively and considered in a pentanucleotide context, 5'-WXGYZ-3', where the central, underlined G represents the reactive guanine and W, X, Y, and Z can be any of the nucleotide bases. Methods are developed to determine that the X (5'-side) base and the Y (3'-side) base are most influential in determining guanine reactivity. The influence of the bases in the 5'-position (X) is 5'-G (1.0) greater than C (0.8) greater than A (0.3) greater than T (0.2), while the influence of the bases in the 3'-position (Y) is 3'-G (1.0) greater than T (0.8) greater than C (0.4) greater than A (0.3). These rules in conjunction with molecular modeling studies (to be published elsewhere) were used to assess the binding sites that might be utilized by AFB1 oxide in its reaction with DNA.

[1]  W. Jencks,et al.  Binding energy, specificity, and enzymic catalysis: the circe effect. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  J. Bishop.  The molecular genetics of cancer. , 1987, Science.

[3]  Victor V Lobanenkov,et al.  The effect of neighbouring bases on G-specific DNA cleavage mediated by treatment with the anti-diol epoxide of benzo[a]pyrene in vitro. , 1986, Carcinogenesis.

[4]  M. Hogan,et al.  High-resolution mapping of carcinogen binding sites on DNA. , 1986, Biochemistry.

[5]  P. Dervan.  Design of sequence-specific DNA-binding molecules. , 1986, Science.

[6]  F. Chen.  Covalent binding of benzo[a]pyrenediol epoxides to polynucleotides. , 1985, Biochemistry.

[7]  L. Hurley,et al.  Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. , 1984, Science.

[8]  W. Haseltine,et al.  High ratio of alkali-sensitive lesions to total DNA modification induced by benzo(a)pyrene diol epoxide. , 1984, The Journal of biological chemistry.

[9]  R. Fuchs.  DNA binding spectrum of the carcinogen N-acetoxy-N-2-acetylaminofluorene significantly differs from the mutation spectrum. , 1984, Journal of molecular biology.

[10]  T. Kunkel.  Mutational specificity of depurination. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Hashimoto,et al.  Sequence selective modification of DNA with muta-carcinogenic 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole. , 1983, Biochemical and biophysical research communications.

[12]  R. Bases,et al.  Site specific cleavage of phi X-174 replicative form DNA after modification by N-acetoxy-N-2-acetylaminofluorene. , 1983, Carcinogenesis.

[13]  L. Grossman,et al.  Enzymatic properties of purified Escherichia coli uvrABC proteins. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Sagher,et al.  Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: uniqueness of adenine nucleotides. , 1983, Biochemistry.

[15]  M. Z. Humayun,et al.  Covalent and noncovalent interactions of aflatoxin with defined deoxyribonucleic acid sequences. , 1983, Biochemistry.

[16]  A. Sancar,et al.  A novel repair enzyme: UVRABC excision nuclease of Escherichia coli cuts a DNA strand on both sides of the damaged region , 1983, Cell.

[17]  J. Miller,et al.  Base substitution mutations induced by metabolically activated aflatoxin B1. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Rich,et al.  Salt-induced conversion of B-DNA to Z-DNA inhibited by aflatoxin B1. , 1983, Science.

[19]  Eugenio Santos,et al.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene , 1982, Nature.

[20]  Cori Bargmann,et al.  Mechanism of activation of a human oncogene , 1982, Nature.

[21]  R. Schaaper,et al.  Role of depurination in mutagenesis by chemical carcinogens. , 1982, Cancer research.

[22]  K. Fowler,et al.  Photochemical epoxidation of aflatoxin B1 and sterigmatocystin: synthesis of guanine-containing adducts , 1982 .

[23]  E. A. Walker,et al.  Problems related to the use of sodium hypochlorite in the detoxification of aflatoxin B1 , 1981 .

[24]  W. Haseltine,et al.  Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Jencks,et al.  Trapping of the oxocarbonium ion intermediate in the hydrolysis of acetophenone dimethyl ketals , 1977 .

[26]  J. Miller,et al.  2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. , 1977, Cancer research.

[27]  R. C. Garner,et al.  Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids , 1977, Nature.

[28]  J. Essigmann,et al.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Ames,et al.  Detection of carcinogens as mutagens: bacterial tester strains with R factor plasmids. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Bull,et al.  Mechanism and catalysis for hydrolysis of acetals, ketals, and ortho esters , 1974 .

[32]  B. Ames,et al.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Ames,et al.  An improved bacterial test system for the detection and classification of mutagens and carcinogens. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Sporn,et al.  Structure-Activity Relationships in DNA Binding and Nuclear Effects of Aflatoxin and Analogs , 1971 .

[35]  K. Rees,et al.  Investigations of the nature of the binding of aflatoxin B 1 with DNA. , 1969, Biochemical pharmacology.

[36]  P. D. Lawley,et al.  FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES. , 1963, The Biochemical journal.

[37]  J. S. Jacobsen,et al.  Chloroperbenzoic acid induced DNA damage and peracid activation of alfatoxin B1. , 1986, Carcinogenesis.

[38]  M. Barbacid,et al.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats , 1985, Nature.

[39]  J. Messing.  [2] New M13 vectors for cloning , 1983 .

[40]  M. Z. Humayun,et al.  Sequence specificity in aflatoxin B1--DNA interactions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Kunkel,et al.  Infidelity of DNA synthesis associated with bypass of apurinic sites. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Saffhill,et al.  Errors in DNA synthesis induced by aflatoxin B1 modification of poly(dC-dG). , 1983, Carcinogenesis.

[43]  J. Essigmann,et al.  Interactions of aflatoxin B1 and alkylating agents with DNA: structural and functional studies. , 1983, Cold Spring Harbor symposia on quantitative biology.

[44]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[45]  W. Jencks.  Catalysis in chemistry and enzymology , 1969 .